Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APTODON: Botox for Neuropathic Pain After Thoracic Surgery
NCT01325090Phase 3Withdrawn
- Sponsor
- CHU de Limoges
- Start
- May 2011
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in neuropathic pain, sponsored by CHU de Limoges. Planned start May 2011; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01325090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325090.